人群研究中远程血生物标志物与纵向认知结局的关系
该研究在1,327名参与者中检测血清t-tau、Nf-L和GFAP,并随访16年认知评估与脑MRI。结果显示这些标志物可预测散发性AD发生、认知下降速度及脑结构变化,提示其作为筛查和预测标志物的潜在价值。
要点
- 血清t-tau、Nf-L和GFAP升高与临床AD发生风险相关,且具有时间特异性。
- 基线t-tau>0.40pg/ml、Nf-L>25.5pg/ml、GFAP>232pg/ml者认知下降更快。
- 基线GFAP>232pg/ml者海马体积下降速度较<160pg/ml者快160%。
核心结论
- 血清t-tau、Nf-L和GFAP可预测散发性AD发生、认知下降及脑结构改变,提示其不仅可用于筛查和预测,还能反映阿尔茨海默病的病理机制。
研究设计与样本
- 研究纳入1,327名参与者(60%为非裔美国人和女性),均接受AD临床评估、居家认知评估和1.5T脑结构MRI,采用单分子阵列技术检测血清t-tau、Nf-L和GFAP。
主要发现
- 血清标志物浓度升高与临床AD发生相关,t-tau在临床AD前8至16年、Nf-L和GFAP在临床AD前4至8年出现时间特异性关联。
- 基线t-tau>0.40pg/ml者16年认知下降速度较最低四分位组快30%,Nf-L>25.5pg/ml者快110%,GFAP>232pg/ml者快130%。
- 基线GFAP>232pg/ml者海马体积下降速度较GFAP<160pg/ml者快160%。
- 基线t-tau较高与第三脑室体积增长更快相关,基线Nf-L和GFAP与皮层厚度下降更快相关。
关键数值与推荐
- 基线t-tau>0.40pg/ml与认知下降速度快30%相关。
- 基线Nf-L>25.5pg/ml与认知下降速度快110%相关。
- 基线GFAP>232pg/ml与认知下降速度快130%相关。
- 基线GFAP>232pg/ml者海马体积下降速度较GFAP<160pg/ml者快160%。
临床怎么用
- 血清t-tau、Nf-L和GFAP可作为散发性AD的筛查和预测生物标志物,并有助于反映认知下降和脑结构改变的进程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The longitudinal association of the blood biomarkers total tau (t-tau), neurofilament light (Nf-L), and glial fibrillary acidic protein (GFAP) with common sporadic Alzheimer disease (AD) and cognitive decline is not established. METHODS: Using a single molecule array technology, ultrasensitive immunoassays for serum concentrations of t-tau, Nf-L, and GFAP were measured in a population sample of 1,327 participants (60% African Americans and women) who had a clinical evaluation for AD, had completed in-home cognitive assessments, and had undergone 1.5T structural magnetic resonance imaging. RESULTS: Higher concentrations of serum biomarkers were associated with the development of clinical AD; especially, the time-specific associations were notable: t-tau 8 to 16 years, and Nf-L and GFAP 4 to 8 years prior to clinical AD. Serum biomarkers were associated with faster cognitive decline over 16 years; baseline t-tau > 0.40pg/ml had 30% faster decline, Nf-L > 25.5pg/ml had 110% faster decline, and GFAP > 232pg/ml had 130% faster decline compared to those in the lowest quartile. Participants with baseline GFAP > 232pg/ml showed 160% faster decline in hippocampal volume compared to those with values < 160pg/ml. Additionally, higher baseline t-tau was associated with faster increase in 3rd ventricular volume, and baseline Nf-L and GFAP were associated with faster decline in cortical thickness. INTERPRETATION: Serum t-tau, Nf-L, and GFAP predict the development of sporadic AD and cognitive decline, and changes in structural brain characteristics, suggesting their usefulness not only as screening and predictive biomarkers, but also in capturing the pathogenesis of Alzheimer dementia. ANN NEUROL 2020;88:1065-1076.
引用
- Rajan KB, Aggarwal NT, McAninch EA, et al. Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study. Ann Neurol. 2020. PMID: 32799383. doi:10.1002/ana.25874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。